Literature DB >> 17301005

Determination of ciclosporin A and its six main metabolites in isolated T-lymphocytes and whole blood using liquid chromatography-tandem mass spectrometry.

Pål Falck1, Heidi Guldseth, Anders Asberg, Karsten Midtvedt, Jan Leo Egge Reubsaet.   

Abstract

A specific and sensitive method for determination of intracellular ciclosporin A (CsA) and its six main metabolites AM1, AM9, AM1c, AM1c9, AM19 and AM4N, in isolated T-lymphocytes and whole blood is described. T-lymphocytes were separated from whole blood using Prepacyte. The analytes were extracted and purified from isolated lymphocytes and whole blood by protein precipitation followed by solid-phase extraction (SPE). The analytes and the internal standard, ciclosporin C (CsC), were separated on a reversed phase C8 column (30 mm x 2.1mm, 3 microm) with a 10 mm x 2 mm, 5 microm Drop-In Guard Cartridge, using gradient elution chromatography and tandem ion trap mass spectrometry detection. The method has been validated in accordance with FDA guidelines and showed linear range from 0.25 to 500 ng/mL for CsA, 0.5 to 500 ng/mL for AM1, AM9 and AM19, 1 to 500 ng/mL for AM4N, AM1c and AM1c9 in intracellular matrix, and 2.5 to 3000 ng/mL for all analytes in whole blood. The applicability of the method is shown on patient samples.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17301005     DOI: 10.1016/j.jchromb.2007.01.039

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  6 in total

Review 1.  Alternative matrices for therapeutic drug monitoring of immunosuppressive agents using LC-MS/MS.

Authors:  Mwlod Ghareeb; Fatemeh Akhlaghi
Journal:  Bioanalysis       Date:  2015       Impact factor: 2.681

2.  Mycophenolic acid concentrations in peripheral blood mononuclear cells are associated with the incidence of rejection in renal transplant recipients.

Authors:  Zaipul I Md Dom; Janet K Coller; Robert P Carroll; Jonathan Tuke; Brett C McWhinney; Andrew A Somogyi; Benedetta C Sallustio
Journal:  Br J Clin Pharmacol       Date:  2018-08-07       Impact factor: 4.335

3.  A population pharmacokinetic model of ciclosporin applicable for assisting dose management of kidney transplant recipients.

Authors:  Pål Falck; Karsten Midtvedt; Thanh Trúc Vân Lê; Live Storehagen; Hallvard Holdaas; Anders Hartmann; Anders Asberg
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

Review 4.  The role of genetics in drug dosing.

Authors:  Nicholas Ware
Journal:  Pediatr Nephrol       Date:  2012-02-23       Impact factor: 3.714

5.  Simultaneous determination of cyclosporine A, tacrolimus, sirolimus, and everolimus in whole-blood samples by LC-MS/MS.

Authors:  Mustafa Karapirli; Murat Kizilgun; Ozgur Yesilyurt; Husamettin Gul; Zeki Ilker Kunak; Emin Ozgur Akgul; Enis Macit; Tuncer Cayci; Yasemin Gulcan Kurt; Ibrahim Aydin; Hakan Yaren; Melik Seyrek; Erdinc Cakir; Halil Yaman
Journal:  ScientificWorldJournal       Date:  2012-05-02

6.  Endomyocardial, intralymphocyte, and whole blood concentrations of ciclosporin A in heart transplant recipients.

Authors:  Ida Robertsen; Pål Falck; Arne K Andreassen; Nina K Næss; Niclas Lunder; Hege Christensen; Lars Gullestad; Anders Asberg
Journal:  Transplant Res       Date:  2013-04-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.